# US 2021/0332374 A1 · Microorganisms and methods for producing cannabinoids and cannabinoid derivatives

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0332374 A1
- Document ID: US20210332374A1
- Status: Published application
- Kind: A1
- Application number: 17/206,126
- Filed: 2021-03-19
- Published: 2021-10-28
- Earliest claimed: 2017-04-27
- Assignees: The Regents of the University of California
- Applicants: The Regents of the University of California
- Inventors: Jay D. KEASLING; Leo D'ESPAUX; Jeff WONG; Xiaozhou LUO; Michael REITER; Charles DENBY; Anna LECHNER
- Web page: https://patentgrep.com/patent/US20210332374A1

## CPC

- C12N 15/81: for yeasts
- C07C 63/04: Monocyclic monocarboxylic acids
- C12N 9/1085: {transferring alkyl or aryl groups other than methyl groups (2.5)}
- C12N 15/70: Vectors or expression systems specially adapted for E. coli
- C12N 15/8243: {involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine}
- C12P 7/42: Hydroxy-carboxylic acids
- C12N 15/52: Genes encoding for enzymes or proenzymes
- C12Y 101/01088: Hydroxymethylglutaryl-CoA reductase (1.1.1.88)
- C12Y 203/01086: Fatty-acyl-CoA synthase (2.3.1.86)
- C12Y 203/01206: 3,5,7-Trioxododecanoyl-CoA synthase (2.3.1.206)
- C12Y 203/0301: Hydroxymethylglutaryl-CoA synthase (2.3.3.10)
- C12Y 205/01102: Geranyl-pyrophosphate—olivetolic acid geranyltransferase (2.5.1.102)
- C12Y 207/01036: Mevalonate kinase (2.7.1.36)
- C12Y 207/04002: Phosphomevalonate kinase (2.7.4.2)
- C12Y 401/01033: Diphosphomevalonate decarboxylase (4.1.1.33), i.e. mevalonate-pyrophosphate decarboxylase
- C12Y 503/03002: Isopentenyl-diphosphate DELTA-isomerase (5.3.3.2)
- C12Y 602/01003: Long-chain-fatty-acid-CoA ligase (6.2.1.3)
- C12Y 604/01002: Acetyl-CoA carboxylase (6.4.1.2)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C07C: ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- C12Y: ENZYMES

## Abstract

The present disclosure provides genetically modified host cells that produce a cannabinoid, a cannabinoid derivative, a cannabinoid precursor, or a cannabinoid precursor derivative. The present disclosure provides methods of synthesizing a cannabinoid, a cannabinoid derivative, a cannabinoid precursor, or a cannabinoid precursor derivative.

## Claims

### Claim at position 1

1-81. (canceled)

### Claim 82

A genetically modified host cell that produces a cannabinoid or cannabinoid derivative, wherein the host cell is genetically modified with:
a) one or more integrated heterologous nucleic acids encoding a tetraketide synthase (TKS) polypeptide;
b) one or more integrated heterologous nucleic acids encoding an olivetolic acid cyclase (OAC) polypeptide;
c) one or more integrated heterologous nucleic acids encoding an acyl-activating enzyme (AAE) polypeptide; and
d) one or more integrated heterologous nucleic acids encoding a geranyltransferase (GOT) polypeptide comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 110 or at least 90% sequence identity to SEQ ID NO: 100.

### Claim 83 (depends on 82)

The genetically modified host cell of claim 82, wherein the cell is genetically modified to comprise between two and four copies of the heterologous nucleic acid encoding a tetraketide synthase (TKS).

### Claim 84 (depends on 82)

The genetically modified host cell of claim 82, wherein the cell is genetically modified to comprise between two and four copies of the heterologous nucleic acid encoding an olivetolic acid cyclase (OAC).

### Claim 85 (depends on 82)

The genetically modified host cell of claim 82, wherein the host cell is further genetically modified with:
a) one or more heterologous nucleic acids encoding a tetrahydrocannabinolic acid (THCA) synthase polypeptide or a cannabidiolic acid (CBDA) synthase polypeptide;
b) one or more heterologous nucleic acids encoding one or more polypeptides that generate geranyl pyrophosphate;
c) one or more heterologous nucleic acids encoding one or more polypeptides that generate hexanoyl-CoA or derivatives thereof; and
d) one or more heterologous nucleic acids encoding one or more polypeptides that generate malonyl-CoA.

### Claim 86 (depends on 85)

The genetically modified host cell of claim 85, wherein the one or more polypeptides that generate malonyl-CoA comprise an acetyl-CoA carboxylase-1 (ACC1) polypeptide.

### Claim 87 (depends on 82)

The genetically modified host cell of claim 82, wherein the host cell is a eukaryotic cell.

### Claim 88 (depends on 87)

The genetically modified host cell of claim 87, wherein the eukaryotic cell is a yeast cell.

### Claim 89 (depends on 88)

The genetically modified host cell of claim 88, wherein the yeast cell is Saccharomyces cerevisiae.

### Claim 90 (depends on 85)

The genetically modified host cell of claim 85, wherein the one or more polypeptides that generate hexanoyl-CoA or derivatives thereof comprise a hexanoyl-CoA synthetase (HCS) polypeptide.

### Claim 91 (depends on 85)

The genetically modified host cell of claim 85, wherein the one or more polypeptides that generate geranyl pyrophosphate comprise a geranyl pyrophosphate synthetase (GPPS) polypeptide.

### Claim 92 (depends on 91)

The genetically modified host cell of claim 91, wherein the GPPS polypeptide is a heterodimeric polypeptide comprising a GPPS large subunit polypeptide and a GPPS small subunit polypeptide.

### Claim 93 (depends on 85)

The genetically modified host cell of claim 85, wherein the one or more polypeptides that generate hexanoyl-CoA or derivatives thereof comprise a MCT1 polypeptide, a PaaH1 polypeptide, a PhaB polypeptide, a PhaJ polypeptide, a Crt polypeptide, a Ter polypeptide, or a BktB polypeptide, or a combination thereof.

### Claim 94 (depends on 82)

The genetically modified host cell of claim 82, wherein at least one of the one or more heterologous nucleic acids encoding a TKS polypeptide, the one or more heterologous nucleic acids encoding the OAC polypeptide, the one or more heterologous nucleic acids encoding the AAE polypeptide, and the one or more heterologous nucleic acids encoding the GOT polypeptide is operably linked to an inducible promoter.

### Claim 95 (depends on 94)

The genetically modified host cell of claim 94, wherein the inducible promoter is a GAL promoter.

### Claim 96

A genetically modified host cell that produces cannabigerol (CBG) or cannabigerolic acid (CBGA), wherein the host cell is genetically modified with:
a) between two and four copies of an integrated heterologous nucleic acid encoding a tetraketide synthase (TKS) polypeptide;
b) between two and four copies of an integrated heterologous nucleic acid encoding an olivetolic acid cyclase (OAC) polypeptide;
c) one integrated heterologous nucleic acid encoding an acyl-activating enzyme (AAE); and
d) one integrated heterologous nucleic acid encoding a geranyltransferase (GOT) polypeptide comprising an amino acid sequence having at least 90% sequence identity to SEQ ID NO: 100,
wherein each of the integrated heterologous nucleic acids of (a)-(d) are operably linked to an inducible GAL promoter.

### Claim 97 (depends on 96)

The genetically modified host cell of claim 96, wherein the integrated heterologous nucleic acid encoding the geranyltransferase (GOT) polypeptide comprises the amino acid sequence of SEQ ID NO: 100.

### Claim 98

A method of producing a cannabinoid or cannabinoid derivative in a genetically modified host cell, the method comprising:
a) culturing the genetically modified host cell in a suitable medium;
wherein the genetically modified host cell comprises:
i) one or more integrated heterologous nucleic acids encoding a tetraketide synthase (TKS) polypeptide;
ii) one or more integrated heterologous nucleic acids encoding an olivetolic acid cyclase (OAC) polypeptide;
iii) one or more integrated heterologous nucleic acids encoding an acyl-activating enzyme (AAE); and
iv) one or more integrated heterologous nucleic acids encoding a geranyltransferase (GOT) polypeptide comprising an amino acid sequence having at least 85% sequence identity to SEQ ID NO: 110 or at least 90% sequence identity to SEQ ID NO: 100;
and
b) recovering the produced cannabinoid or cannabinoid derivative.

### Claim 99 (depends on 98)

The method of claim 98, wherein the genetically modified host cell further comprises
a) one or more heterologous nucleic acids encoding a tetrahydrocannabinolic acid (THCA) synthase polypeptide or a cannabidiolic acid (CBDA) synthase polypeptide;
b) one or more heterologous nucleic acids encoding one or more polypeptides that generate geranyl pyrophosphate;
c) one or more heterologous nucleic acids encoding one or more polypeptides that generate hexanoyl-CoA or derivatives thereof; and
d) one or more heterologous nucleic acids encoding one or more polypeptides that generate malonyl-CoA.

### Claim 100 (depends on 99)

The method of claim 99, wherein culturing the genetically modified host cell in suitable medium comprising hexanoic acid provides for production of an increased amount of the cannabinoid or cannabinoid derivative compared to that produced by culturing the genetically modified host cell in suitable medium lacking hexanoic acid.

### Claim 101 (depends on 98)

The method of claim 98, wherein the cannabinoid is cannabigerol or cannabigerolic acid.
